Mesenchymal stem cell secretome attenuates disease-associated microglial activation and cognitive decline in TBI-associated neuroinflammation.
Rasiah PK., Ismael S., Elshaer S., Awad AM., Salman M., Wang Z.
Animal Study on Neuroinflammation, published in Neurochem Int (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Neurochem Int (2026)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42342036
- DOI
- 10.1016/j.neuint.2026.106210
Abstract (original English)
Therapeutic options for traumatic brain injury (TBI) remain limited, in part due to injury-induced activation of microglia toward disease-associated microglia (DAM) phenotypes that contribute to persistent neuroinflammation and cognitive decline. We evaluated whether non-invasive intranasal delivery of mesenchymal stem cell secretome can enhance recovery after TBI by modulating microglial DAM signaling. Adult C57BL/6 mice underwent moderate controlled cortical impact (CCI) TBI. Adipose Stem Cell-derived Concentrated Conditioned Media (ASC-CCM) (∼20 ng protein/day, four doses) was administered intranasally, while sham and TBI controls received saline. Cognitive and memory functions assessed at 7 and 30 days post-injury showed TBI mice with impairments in learning, working, and long-term memory, while ASC-CCM-treated TBI mice performed similar to sham. These functional deficits correlated with increased astrogliosis (GFAP) and apoptosis (TUNEL), both of which were attenuated by ASC-CCM. TBI induced a time-dependent increase in astrocyte-associated APOE in the ipsilateral peri-lesion area and TYROBP in activated microglia near the impact site; ASC-CCM treatment significantly reduced both markers. Transcriptomic analysis of peri-lesion tissue at days 7 and 30 confirmed robust upregulation of DAM-associated genes (APOE, TYROBP, TREM2) after TBI, which was mitigated by intranasal ASC
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Adipose-Derived Stem Cells in Traumatic Brain Injury: A Systematic Review of Preclinical Studies.
Systematic Review on Neuroinflammation, published in Tissue Eng Regen Med (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Eng Regen Med - Level ASystematic ReviewPubMed
The use of cellular therapies for trigeminal neuralgia: a systematic review of behavioral and molecular outcomes.
Systematic Review with a reported sample of 8 on Neuroinflammation, published in Neurosurg Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 8
Neurosurg Rev - Level ASystematic ReviewEurope PMC
Factor XII-A New Therapeutic Target? A Systematic Review
Systematic Review on Cardiovascular Disease, Neuroinflammation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci1 citations - Level ASystematic ReviewEurope PMC
Efficacy of Exosome-Based Therapies for Skin Rejuvenation: A Systematic Review of Human Studies
Systematic Review on Neuroinflammation, Skin Aging, published in Cureus (2026) — summary generated from the PubMed abstract.
- 2026
Cureus - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol - Level ASystematic ReviewEurope PMC
Safety and Efficacy of Mesenchymal Stem Cell Therapy in Multiple System Atrophy: Systematic Review
Systematic Review with a reported sample of 123 on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Biologics (2026) — summary generated from the PubMed abstract.
- 2026
- n = 123
Biologics